OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
01781060

Pulmuone Corporate

Food ProcessingVerified

Pulmuone Corporate has a liquidity risk profile marked by a debt-to-equity ratio of 4.02, indicating a high leverage position relative to its equity base. The company's current ratio of 0.72 suggests that it may struggle to meet short-term obligations with its current assets, which is below the typical threshold of 1.0 for financial health. The company's cash and equivalents amount to 124,550,938,010 KRW, but this is significantly less than its long-term debt of 1,247,168,884,480 KRW, resulting in a negative net cash position. In terms of profitability, Pulmuone Corporate's return on equity (ROE) is 5.84%, which is relatively low for a company in the food processing industry. The return on assets (ROA) is even lower at 0.77%, indicating that the company is not efficiently utilizing its assets to generate profits. These metrics suggest that the company's profitability is below the industry average, which is typically higher for firms with strong brand recognition and diversified product lines. The company's revenue is distributed across five segments, with the Domestic Food Manufacturing and Distribution segment being the primary contributor. However, the company's geographic exposure is heavily concentrated in Korea, which may limit its growth potential in international markets. The Health Care Manufacturing and Distribution segment is a newer area of focus, but it remains a smaller contributor to overall revenue. Looking at the company's growth trajectory, the outlook for the current fiscal year is mixed. The company's revenue is expected to remain relatively flat, with no significant growth anticipated in the near term. The capital expenditure of -154,467,182,790 KRW indicates a reduction in investment, which may signal a strategic shift or financial constraints. The company's free cash flow of 26,198,528,549.9998 KRW is positive but modest, suggesting limited capacity for reinvestment or shareholder returns. The risk assessment for Pulmuone Corporate highlights several key concerns. The liquidity risk is rated as medium, primarily due to the company's high debt levels and low current ratio. The dilution risk is rated as low, but the company's capital structure leaves it vulnerable to financial stress in the event of a downturn. The key flag of negative net cash after subtracting total debt underscores the company's reliance on external financing to maintain operations. Recent events and filings indicate that the company has not issued any new shares or raised additional capital in the recent period. The analyst estimates suggest a neutral outlook, with a mean price target of 17,000 KRW and a mean recommendation of 2.00, which is a "buy" rating. However, the lack of strong buy recommendations and the absence of a hold rating suggest that analysts are not particularly bullish on the company's prospects.

30-day price · 017810-1140.00 (-9.5%)
Low$10650.00High$12730.00Close$10870.00As of22 May, 00:00 UTC
Profile
CompanyPulmuone Corporate
Ticker017810.KS
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Pulmuone Corporate is a Korea-based holding company primarily engaged in the manufacture and distribution of food products, operating through five segments including domestic and overseas food manufacturing, food service distribution, health care manufacturing, and a holding segment.

Classification. Pulmuone Corporate is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry, with a classification confidence of 0.92.

Pulmuone Corporate has a liquidity risk profile marked by a debt-to-equity ratio of 4.02, indicating a high leverage position relative to its equity base. The company's current ratio of 0.72 suggests that it may struggle to meet short-term obligations with its current assets, which is below the typical threshold of 1.0 for financial health. The company's cash and equivalents amount to 124,550,938,010 KRW, but this is significantly less than its long-term debt of 1,247,168,884,480 KRW, resulting in a negative net cash position. In terms of profitability, Pulmuone Corporate's return on equity (ROE) is 5.84%, which is relatively low for a company in the food processing industry. The return on assets (ROA) is even lower at 0.77%, indicating that the company is not efficiently utilizing its assets to generate profits. These metrics suggest that the company's profitability is below the industry average, which is typically higher for firms with strong brand recognition and diversified product lines. The company's revenue is distributed across five segments, with the Domestic Food Manufacturing and Distribution segment being the primary contributor. However, the company's geographic exposure is heavily concentrated in Korea, which may limit its growth potential in international markets. The Health Care Manufacturing and Distribution segment is a newer area of focus, but it remains a smaller contributor to overall revenue. Looking at the company's growth trajectory, the outlook for the current fiscal year is mixed. The company's revenue is expected to remain relatively flat, with no significant growth anticipated in the near term. The capital expenditure of -154,467,182,790 KRW indicates a reduction in investment, which may signal a strategic shift or financial constraints. The company's free cash flow of 26,198,528,549.9998 KRW is positive but modest, suggesting limited capacity for reinvestment or shareholder returns. The risk assessment for Pulmuone Corporate highlights several key concerns. The liquidity risk is rated as medium, primarily due to the company's high debt levels and low current ratio. The dilution risk is rated as low, but the company's capital structure leaves it vulnerable to financial stress in the event of a downturn. The key flag of negative net cash after subtracting total debt underscores the company's reliance on external financing to maintain operations. Recent events and filings indicate that the company has not issued any new shares or raised additional capital in the recent period. The analyst estimates suggest a neutral outlook, with a mean price target of 17,000 KRW and a mean recommendation of 2.00, which is a "buy" rating. However, the lack of strong buy recommendations and the absence of a hold rating suggest that analysts are not particularly bullish on the company's prospects.
Key takeaways
  • Pulmuone Corporate has a high debt-to-equity ratio of 4.02, indicating a leveraged capital structure.
  • The company's return on equity (5.84%) and return on assets (0.77%) are below industry norms, suggesting inefficiencies in asset utilization and profitability.
  • The company's revenue is heavily concentrated in Korea, with limited international diversification.
  • The company's free cash flow is positive but modest, limiting its ability to reinvest or return value to shareholders.
  • Analysts have a neutral outlook on the company, with a mean price target of 17,000 KRW and a "buy" recommendation.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's gross profit margin is expected to remain stable, driven by consistent demand for its core food products.
  • **rd_outlook_rationale**: Research and development spending is expected to remain low, as the company focuses on optimizing existing product lines.
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$3.38T
Gross profit$831.62B
Operating income$89.88B
Net income$18.09B
R&D
SG&A
D&A
SBC
Operating cash flow$163.75B
CapEx-$154.47B
Free cash flow$26.20B
Total assets$2.35T
Total liabilities$2.04T
Total equity$310.10B
Cash & equivalents$124.55B
Long-term debt$1.25T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$310.10B
Net cash-$1.12T
Current ratio0.7
Debt/Equity4.0
ROA0.8%
ROE5.8%
Cash conversion9.1%
CapEx/Revenue-4.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
Metric017810Activity
Op margin2.7%3.3% medp25 2.5% · p75 4.5%below median
Net margin0.5%3.0% medp25 1.5% · p75 6.7%bottom quartile
Gross margin24.6%24.0% medp25 20.2% · p75 35.3%above median
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-4.6%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity402.0%33.5% medp25 29.1% · p75 81.5%top quartile
Observations
IR observations
Mean price target17,000.00 KRW
Median price target17,000.00 KRW
High price target17,000.00 KRW
Low price target17,000.00 KRW
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1,266.50 KRW
Last actual EPS83.00 KRW
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 14:34 UTC#9d9eb668
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 14:35 UTCJob: 81bfb6fa